The strategic forecast for the Cancer Diagnostics Market indicates robust double-digit expansion, largely propelled by the commercial maturity and widespread clinical adoption of highly advanced diagnostic technology. The most significant influence on this forecast is the expected exponential growth of liquid biopsy testing. As assay sensitivity and standardization improve, liquid biopsies are...